<http://webisa.webdatacommons.org/49331344>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/49331344>	<http://www.w3.org/ns/prov#value>	"complication of the disease.- URIPAN XR, like other anticholinergic drugs, may decrease gastrointestinal motility and should be used with caution in patients with conditions such as ulcerative colitis, and intestinal atony.- URIPAN XR should be used with caution in patients who have gastroesophageal reflux and/or who are concurrently taking drugs (such as bisphosphonates) that can cause or exacerb" .
<http://webisa.webdatacommons.org/prov/434967192>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/49331344> .
<http://webisa.webdatacommons.org/49331344>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<adwia.com> .